Starch-Free Diet and the Ebringer Hypothesis

Table of Contents

  1. Who Was Alan Ebringer?
  2. The Molecular Mimicry Hypothesis
  3. Why Starch?
  4. The London AS Diet — Basics
  5. What's the Evidence?
  6. Modern Gut-Microbiome Research
  7. How to Try It Safely
  8. Low-Starch vs Keto vs AIP vs Mediterranean
  9. Foods to Avoid
  10. Foods Allowed Generously
  11. A Practical Sample Day
  12. Supplements Often Paired
  13. Signs It's Working
  14. Limits and Risks
  15. What Researchers Are Watching
  16. Key Research Papers
  17. Research Papers
  18. Connections

If you have AS, you have probably run into the "low-starch diet" on a forum, a podcast, or in a 1990s paperback called The New Arthritis Breakthrough by Henry Scammell and Thomas Brown. Somewhere in that thread there is usually a reference to an Alan Ebringer and Klebsiella pneumoniae. This page is an honest look at that hypothesis — what it claims, what the evidence actually says, and how to give it a fair trial without wrecking your nutrition or replacing real medical care.

Who Was Alan Ebringer?

Alan Ebringer (1936–2018) was an Australian-born rheumatologist and immunologist who spent most of his career at King's College London, where he ran a rheumatology clinic and immunology research group for roughly four decades. He was a clinician first and a theorist second: his patients were real AS sufferers being seen at the Middlesex Hospital and later King's, and the "London AS Diet" grew out of what he watched work in that clinic.

Ebringer published steadily from the late 1970s through the 2010s on a single big idea: that many chronic autoimmune diseases are triggered and sustained by specific gut or urinary bacteria whose surface proteins look enough like human self-tissue to fool the immune system. For AS, the suspect bacterium was Klebsiella pneumoniae. For rheumatoid arthritis, it was Proteus mirabilis. For multiple sclerosis, Acinetobacter. He argued, with steady consistency, that reducing the bacterial load by dietary means could reduce disease activity.

Mainstream rheumatology never fully embraced him, but it also never cleanly refuted him. He was taken seriously enough to publish in peer-reviewed journals for forty years, and many of his clinic patients — some of whom are still posting on AS forums today — credit his diet with keeping them functional for decades.

The Molecular Mimicry Hypothesis

The core idea is simple, and the biology behind it is real. Molecular mimicry is the phenomenon in which a short amino-acid sequence on a microbe happens to resemble a short sequence on a human protein closely enough that antibodies (or T-cell receptors) raised against the microbe also bind the human protein. When that happens in the wrong tissue, you get autoimmune damage.

Ebringer's group identified two key resemblances:

The proposed chain of events: HLA-B27-positive person has chronic low-grade Klebsiella overgrowth in the gut, their immune system makes antibodies against Klebsiella, those antibodies (and cross-reactive T cells) then bind HLA-B27-bearing cells and collagen-rich tissue in the spine and sacroiliac joints, and the resulting friendly fire is what shows up on MRI as sacroiliitis. Ebringer's cohort studies repeatedly measured elevated serum IgA anti-Klebsiella antibodies in active AS patients compared with healthy HLA-B27 controls, and he argued this was the fingerprint of the process.

Is mimicry alone sufficient to cause disease? Probably not — plenty of people carry cross-reactive antibodies without getting sick. But mimicry combined with HLA-B27's unusual biology (see HLA-B27 Explained), increased gut permeability, and a genetically primed IL-23/IL-17 axis is a plausible multi-hit explanation for why AS happens.

Why Starch?

Klebsiella pneumoniae is a facultative anaerobe that ferments a wide range of sugars, but it is particularly efficient at fermenting complex starches in the colon. In laboratory culture, Klebsiella grows faster on starch-rich media than many competing gut organisms. Ebringer's working hypothesis was that a high dietary starch intake feeds Klebsiella preferentially, inflating its population relative to other gut bacteria, which in turn keeps the immune system chronically primed against it.

The logic of the diet, then: if you starve Klebsiella of its preferred substrate, the population drops, the anti-Klebsiella antibody titre drops, the cross-reactive attack on your spine eases off, and symptoms improve. Ebringer measured all three endpoints (dietary starch intake, IgA anti-Klebsiella, BASDAI scores) in uncontrolled cohorts and reported that they moved together.

Critics rightly point out that "starch feeds Klebsiella" is an oversimplification. Most dietary starch is digested in the small intestine and never reaches the colon intact; only resistant starch (found in cooled potato, unripe banana, legumes, whole grains) actually reaches Klebsiella's habitat. Ebringer's diet is still built around cutting total starch, not just resistant starch, so the mechanism may be partly wrong even if the clinical effect is real.

The London AS Diet — Basics

In its simplest form the diet is:

There is no calorie counting, no macro-tracking, and no fasting requirement. The rule of thumb is: if it tests positive with iodine (the classic starch stain), cut it. Sugar, honey, and most fruit are allowed because simple sugars are absorbed in the small intestine and do not reach the colon to feed Klebsiella.

That last point surprises many patients: Ebringer's diet is not low-carb in the ketogenic sense. You can eat apples, grapes, berries, and even a modest amount of table sugar. What you cut is specifically complex starch.

What's the Evidence?

This is where honesty matters. The evidence for the London AS Diet is suggestive but not conclusive.

What we have:

What we don't have:

The fair summary: Ebringer's hypothesis is plausible and intriguing, but not proven. It sits in the "worth trying if you're motivated, doesn't replace real treatment" tier — roughly where Mediterranean-diet recommendations sat 25 years ago before the evidence caught up.

Modern Gut-Microbiome Research

A striking twist: twenty-first-century microbiome research, done with 16S ribosomal RNA sequencing rather than Ebringer's old antibody assays, has independently confirmed that AS patients have a distinctive gut microbiome. Findings that line up (at least loosely) with Ebringer's picture:

None of this proves the Ebringer story. But it does mean the fundamental idea — that AS is a gut-joint axis disease — has aged better than anyone expected in 1980.

How to Try It Safely

If you want to test the diet on yourself, do it like a clinical trial of one:

  1. Pick a start date and a 6–8-week window. Shorter trials don't give gut flora time to shift; longer-than-8-week blind trials make it hard to tell diet from seasonal change.
  2. Record a baseline. Write down your current BASDAI score (you can score yourself online), current morning stiffness duration, current NSAID use, and ideally a recent CRP and ESR from bloodwork.
  3. Keep a simple food diary. One line per day: what you ate, stiffness on waking (0–10), fatigue (0–10), flares.
  4. Don't change your medications. Stay on NSAIDs, biologics, DMARDs exactly as prescribed. The diet is additive, not a replacement.
  5. If you're starting with severe restriction or are already underweight, see a registered dietitian or nutritionist once before starting. Losing too much weight on an AS diet is counterproductive.
  6. At week 6–8, re-score your BASDAI and re-check CRP/ESR. Compare. If nothing's moved — stop. The diet is cheap but it isn't free, and an 8-week fair test is plenty.

Low-Starch vs Keto vs AIP vs Mediterranean

Patients often conflate these, but they are very different protocols:

The low-starch diet is by far the least restrictive of the four — if you can give up bread, pasta, potato, and rice, you can keep almost everything else on your plate. That's also why it's easier to sustain for the long run.

Foods to Avoid

Foods Allowed Generously

A Practical Sample Day

Notice there is no bread, rice, pasta, or potato — but the plate looks full, and nobody feels deprived. That's the point. A sustainable AS diet is one you can eat for years, not one you abandon in a month.

Supplements Often Paired

Ebringer did not build a supplement protocol into the diet, but patients and modern integrative rheumatologists commonly add:

None of these are substitutes for disease-modifying therapy. They are add-ons.

Signs It's Working

Give the diet 6–8 weeks of strict adherence before deciding. If it is going to help you, you typically see some combination of:

If none of those move after 8 strict weeks, the diet is probably not your lever. That is useful information too — AS is heterogeneous, and not every patient's disease is driven by the same gut biology.

Limits and Risks

Honesty again:

What Researchers Are Watching

The gut-joint axis in AS is one of the hotter areas of rheumatology research right now. Developments worth tracking:

It is entirely possible that within a decade some modernized version of Ebringer's central intuition — feed the right microbes, starve the wrong ones, and AS calms down — will be standard adjunctive care. It is also possible the specific starch-Klebsiella story will be superseded by something more granular. Either way, Ebringer asked the right question forty years early.

Key Research Papers

Research Papers

For further reading, the following PubMed topic searches return peer-reviewed work on the Ebringer hypothesis, the low-starch diet, and the AS gut microbiome:

  1. Ebringer, Klebsiella, and ankylosing spondylitis
  2. Low-starch diet and ankylosing spondylitis
  3. HLA-B27 and the gut microbiome
  4. Klebsiella pneumoniae and spondylitis
  5. Molecular mimicry in ankylosing spondylitis
  6. Gut-joint axis and spondyloarthritis
  7. Probiotics and ankylosing spondylitis
  8. Fecal microbiota transplantation in spondyloarthritis

Connections

Back to Table of Contents